Cardinal Health (NYSE: CAH) today announced that Victor Crawford will be joining the company as its next CEO of the Pharmaceutical Segment.
Recent News About Cardinal Health, Inc View More
CARDINAL HEALTH, INC: Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2019 on November 8
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2019 on November 8 prior to the opening of trading on the New York Stock Exchange.
The Cardinal Health (NYSE: CAH) board of directors today approved a quarterly dividend of $0.4763 per share.